 BOSTON and ROCKVILLE, Md., May 05, 2021 GLOBE NEWSWIRE -- Sensei Biotherapeutics, Inc. NASDAQ: SNSE, a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointments of Maura Gillison, M.D., Ph.D., Professor of Medicine, ThoracicHead and Neck Medical Oncology at MD Anderson Cancer Center, and Richard Ulevitch, Ph.D., Professor of Immunology and Chairman Emeritus at The Scripps Research Institute, to its Immuno-Oncology Advisory Board. 